BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Long-acting ANP analog (LY3971297) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Long-acting ANP analog (LY3971297)\, from
  ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07547540-569@assetmemo.bio
DTSTAMP:20261121T011043Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:Long-acting ANP analog (LY3971297): Phase 1 readout est. (NCT075475
 40)
DESCRIPTION:Long-acting ANP analog (LY3971297)\, phase 1\, Heart Failure.\n
 Study: A Study of LY3971297 in Participants With Heart Failure\nEstimated 
 primary completion: November 2027. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/long-acting-anp-analog-ly3971297#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07547540
URL:https://assetmemo.bio/drug/long-acting-anp-analog-ly3971297#upcoming-ev
 ents
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
